This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Oct;30(5):417-21.

doi: 10.1111/j.1365-2710.2005.00671.x.

Valproate: a simple chemical with so much to offer

G M Peterson¹, M Naunton

Affiliations

PMID: 16164485
DOI: 10.1111/j.1365-2710.2005.00671.x

Review

Valproate: a simple chemical with so much to offer

G M Peterson et al. J Clin Pharm Ther. 2005 Oct.

. 2005 Oct;30(5):417-21.

doi: 10.1111/j.1365-2710.2005.00671.x.

Authors

G M Peterson¹, M Naunton

Affiliation

¹ Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia. g.peterson@utas.edu.au

PMID: 16164485
DOI: 10.1111/j.1365-2710.2005.00671.x

No abstract available

PubMed Disclaimer

Similar articles

The history of valproate in clinical neuroscience.
Henry TR. Henry TR. Psychopharmacol Bull. 2003;37 Suppl 2:5-16. Psychopharmacol Bull. 2003. PMID: 14624229 Review.
The remarkable story of valproic acid.
Tomson T, Battino D, Perucca E. Tomson T, et al. Lancet Neurol. 2016 Feb;15(2):141. doi: 10.1016/S1474-4422(15)00398-1. Epub 2016 Jan 12. Lancet Neurol. 2016. PMID: 28463122 No abstract available.
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
Löscher W. Löscher W. CNS Drugs. 2002;16(10):669-94. doi: 10.2165/00023210-200216100-00003. CNS Drugs. 2002. PMID: 12269861 Review.
[Therapeutic drug monitoring of valproate].
Bentué-Ferrer D, Tribut O, Verdier MC; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Bentué-Ferrer D, et al. Therapie. 2010 May-Jun;65(3):233-40. doi: 10.2515/therapie/2010029. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699076 Review. French.
Role of valproate across the ages. Treatment of epilepsy in adults.
Ben-Menachem E, Schmitz B, Tomson T, Vajda F. Ben-Menachem E, et al. Acta Neurol Scand Suppl. 2006;184:14-27. doi: 10.1111/j.1600-0404.2006.00667.x. Acta Neurol Scand Suppl. 2006. PMID: 16776493 Review.

See all similar articles

Cited by

Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.
Sriram A, Ward HE, Hassan A, Iyer S, Foote KD, Rodriguez RL, McFarland NR, Okun MS. Sriram A, et al. J Neurol. 2013 Feb;260(2):521-7. doi: 10.1007/s00415-012-6669-1. Epub 2012 Sep 25. J Neurol. 2013. PMID: 23007193
PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
Vallée A, Vallée JN, Lecarpentier Y. Vallée A, et al. Mol Psychiatry. 2019 May;24(5):643-652. doi: 10.1038/s41380-018-0131-4. Epub 2018 Aug 13. Mol Psychiatry. 2019. PMID: 30104725 Review.
Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL, Zhan L, Eid A, Zarbl H, Guo GL, Richardson JR. Green AL, et al. Neuropharmacology. 2017 Oct;125:189-196. doi: 10.1016/j.neuropharm.2017.07.020. Epub 2017 Jul 22. Neuropharmacology. 2017. PMID: 28743636 Free PMC article.
Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
Chang R, Chou MC, Hung LY, Wang ME, Hsu MC, Chiu CH. Chang R, et al. Biomed Res Int. 2016;2016:9576503. doi: 10.1155/2016/9576503. Epub 2016 Feb 29. Biomed Res Int. 2016. PMID: 27034954 Free PMC article.
Differential Expression of Multiple Disease-Related Protein Groups Induced by Valproic Acid in Human SH-SY5Y Neuroblastoma Cells.
Hu TM, Chung HS, Ping LY, Hsu SH, Tsai HY, Chen SJ, Cheng MC. Hu TM, et al. Brain Sci. 2020 Aug 12;10(8):545. doi: 10.3390/brainsci10080545. Brain Sci. 2020. PMID: 32806546 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- ClinicalTrials.gov